期刊文献+

极低体重颈胸腹联体儿分离术后连续性肾脏替代治疗的护理 被引量:1

Nursing care of a very low birth weight twin with continuous renal replacement treatment after dissection of neck-chest-abdominal conjoined
原文传递
导出
摘要 总结了1对极低体重颈胸联体儿分离术后连续性肾脏替代治疗的护理体会。联体儿分离术后并发多器官功能衰竭,行连续性肾脏替代治疗。在25次治疗过程中,通过管路、体外循环的管理,抗凝剂的使用,参数的设定和观察,生命体征的监测,液体的管理等方面的护理措施,保证了治疗的顺利进行,有效地纠正了电解质、酸碱失衡,改善患儿的肺功能和肝肾功能,延长了生命。
出处 《中华护理杂志》 CSCD 北大核心 2011年第9期931-932,共2页 Chinese Journal of Nursing
关键词 双生 联体 肾替代治疗 护理 Twins,Conjoined Renal Replacement Treatment Nursing Care
  • 相关文献

参考文献3

  • 1Goldstein SL,Somers MJ,Brophy PD,et al. The prospective Pediatric Continuous Renal Replacement Therapy(ppCRRT)Registry:Design,Development and Data Assessed[J]. Int J Artif Organs,2004,27(1):9-14.
  • 2Fakhrossadat M,Sedigeh HS,Nayyer N. Acute kidney failure in neonatal period[JJ. Iran J Kidney Dis,2009,3(3):136-139.
  • 3张莉,孙雪峰,张冬,马志芳,茅玉梅,魏日胞,陈香美.不同抗凝剂对血液透析过程凝血状态的影响[J].中华肾脏病杂志,2009,25(5):335-340. 被引量:17

二级参考文献10

  • 1Furuhashi M, Ura N, Hasegawa K, et al. Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis. Nephrol Dial Transplant, 2002, 17: 1457-1462.
  • 2Molino D, De Santo NG, Marotta R, et al. Plasma levels of plasminogen activator inhibitor type 1, factor Ⅷ, protbrombin activation fragment 1 +2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients. Semin Nephrol, 2004, 24: 495-501.
  • 3Sirolli V, Strizzi L, Di Stante S, et al. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. Thromb Haemost, 2001, 86: 834- 839.
  • 4Nutescu EA, Shapiro NL, Chevalier A, et al. A pharmacologic overview of current and emerging anticoagulants. Cleve Clin J Med, 2005, 72: S2-S6.
  • 5Mckeage K, Plosker GL. Argatroban. Drugs, 2001, 61: 515- 522.
  • 6Fischer KG. Essentials of anticoagulation in hemodialysis. Hemodial Int, 2007, 11: 178-189.
  • 7Fareed J, Ma Q. Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosisl Semin Thromb Hemost, 2004, 30: 89-104.
  • 8Tang IY, Cox DS, Patel K, et al. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother, 2005, 39: 231-236.
  • 9Sagedal S, Hartmann A, Sundstrφm K, et al. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets. Nephrol Dial Transplant, 2001, 16: 987-993.
  • 10孙雪峰,周希静.维持性血液透析患者内瘘阻塞因素的探讨[J].中华肾脏病杂志,1998,14(1):51-51. 被引量:35

共引文献16

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部